Max Robotics — Global Service Robot Directory + US Certification

About

Pei-Hsuan Chu is a biomedical researcher specializing in stem cell biology, biomanufacturing, and translational medicine, with a particular focus on human pluripotent stem cells (hPSCs) and their therapeutic applications. Chu's most significant contributions lie at the intersection of automation and stem cell science, pioneering robotic high-throughput platforms for the scalable manufacturing and functional differentiation of human induced pluripotent stem cells (hiPSCs). This landmark work, which has garnered over 68 citations since 2021, addresses critical bottlenecks in traditional manual cell culture methods — namely variability and labor intensity — offering transformative solutions for high-throughput biomedical applications. Chu has also made notable strides in pain research, developing efficient, reproducible protocols for differentiating hPSCs into sensory neurons, including pseudo-unipolar subtypes relevant to nociception. Published in 2023 and already accumulating 48 citations, this work holds significant promise for advancing the development of non-addictive analgesics, a pressing public health priority. By grounding differentiation strategies in developmental biology principles, Chu bridges fundamental science with real-world translational impact. Collectively, this body of work positions Chu as an emerging leader in scalable stem cell biomanufacturing and disease-relevant cell model development.